CO6321284A2 - Compuestos triciclicos que contienen nitrogeno y su uso como antibacteriales - Google Patents

Compuestos triciclicos que contienen nitrogeno y su uso como antibacteriales

Info

Publication number
CO6321284A2
CO6321284A2 CO10145594A CO10145594A CO6321284A2 CO 6321284 A2 CO6321284 A2 CO 6321284A2 CO 10145594 A CO10145594 A CO 10145594A CO 10145594 A CO10145594 A CO 10145594A CO 6321284 A2 CO6321284 A2 CO 6321284A2
Authority
CO
Colombia
Prior art keywords
antibacterials
compounds containing
containing nitrogen
cmh2m
alkyl
Prior art date
Application number
CO10145594A
Other languages
English (en)
Inventor
Carlos Alemparte-Gallardo
Christopher Barfoot
David Barros-Aguirre
Monica Cacho-Izquierdo
Roman Jose Maria Fiandor
Alan Joseph Hennessy
Neil David Pearson
Modesto Jesus Remuinan-Blanco
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CO6321284A2 publication Critical patent/CO6321284A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1.- Un compuesto de formula (I) o una sal o N-óxido farmacéuticamente aceptable del mismo:donde:uno de Z1 y Z2 es CH o N y el otro es CH;U representa un grupo seleccionado de: fenilo, piridilo, piridazinilo, pirimidinilo, pirazinilo, tiazolilo, furanilo, imidazolilo y tiofenilo;N es 0 ó 1;R5 y R6 se seleccionan independientemente entre: halo, CF3, OCF3, alquilo C1-3, NHR7, NR7AR7B, alcoxi C1-3, nitro y ciano; o R5 puede ser un grupo -CmH2m-A en el que m es 1-5 y el resto CmH2m- puede ser una cadena recta o ramificada y A se selecciona entre OH, OR7, OCOR7, OCO2R7, OCONR7, OPO2R7 y NH2, donde R7, R7A, R7B es alquilo C1-5.
CO10145594A 2008-05-23 2010-11-19 Compuestos triciclicos que contienen nitrogeno y su uso como antibacteriales CO6321284A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08382018 2008-05-23
EP08382044 2008-10-17
EP08382057 2008-10-17

Publications (1)

Publication Number Publication Date
CO6321284A2 true CO6321284A2 (es) 2011-09-20

Family

ID=40874958

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10145594A CO6321284A2 (es) 2008-05-23 2010-11-19 Compuestos triciclicos que contienen nitrogeno y su uso como antibacteriales

Country Status (24)

Country Link
US (1) US8097628B2 (es)
EP (1) EP2300476B1 (es)
JP (1) JP5474941B2 (es)
KR (1) KR20110016947A (es)
CN (1) CN102105473B (es)
AR (1) AR071869A1 (es)
AU (1) AU2009248786B2 (es)
BR (1) BRPI0912995A2 (es)
CA (1) CA2725726A1 (es)
CL (1) CL2009001267A1 (es)
CO (1) CO6321284A2 (es)
CR (1) CR11838A (es)
DO (1) DOP2010000342A (es)
EA (1) EA018817B1 (es)
ES (1) ES2455496T3 (es)
IL (1) IL209270A (es)
MA (1) MA32406B1 (es)
MX (1) MX2010012732A (es)
NZ (1) NZ589062A (es)
PE (1) PE20091927A1 (es)
TW (1) TW201008941A (es)
UY (1) UY31839A (es)
WO (1) WO2009141398A1 (es)
ZA (1) ZA201007945B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009141386A1 (en) 2008-05-23 2009-11-26 Novartis Ag Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
JP5857040B2 (ja) 2010-05-04 2016-02-10 アルカーメス ファーマ アイルランド リミテッド 酸化ラクタム化合物の合成方法
WO2013164769A1 (en) 2012-05-02 2013-11-07 Lupin Limited Substituted pyridine compounds as crac modulators
CN103113291B (zh) * 2013-02-04 2015-03-04 浙江大学 一种3位烯基吡啶衍生物的合成方法
TW201618779A (zh) * 2014-08-22 2016-06-01 葛蘭素史克智慧財產發展有限公司 方法
CA3025624A1 (en) 2016-06-08 2017-12-14 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. New antibacterial compounds
WO2021198981A1 (en) 2020-04-01 2021-10-07 Janssen Biopharma, Inc. Antiviral compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732460B2 (en) * 2005-12-22 2010-06-08 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
JP2009532423A (ja) * 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌剤としてのピロロ−キノキサリノン誘導体
BRPI0810064B8 (pt) * 2007-04-20 2021-05-25 Glaxo Group Ltd compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
EP2300476A1 (en) 2011-03-30
CL2009001267A1 (es) 2010-12-31
MA32406B1 (fr) 2011-06-01
WO2009141398A1 (en) 2009-11-26
CN102105473A (zh) 2011-06-22
IL209270A (en) 2013-09-30
EA201071352A1 (ru) 2011-06-30
EA018817B1 (ru) 2013-10-30
CR11838A (es) 2011-03-25
US20090306089A1 (en) 2009-12-10
JP2011520943A (ja) 2011-07-21
AU2009248786A1 (en) 2009-11-26
ZA201007945B (en) 2011-08-31
JP5474941B2 (ja) 2014-04-16
DOP2010000342A (es) 2010-11-30
US8097628B2 (en) 2012-01-17
UY31839A (es) 2009-12-14
IL209270A0 (en) 2011-01-31
AR071869A1 (es) 2010-07-21
EP2300476B1 (en) 2014-01-08
CA2725726A1 (en) 2009-11-26
KR20110016947A (ko) 2011-02-18
PE20091927A1 (es) 2010-01-21
TW201008941A (en) 2010-03-01
AU2009248786B2 (en) 2013-04-04
MX2010012732A (es) 2010-12-07
ES2455496T3 (es) 2014-04-15
NZ589062A (en) 2012-06-29
BRPI0912995A2 (pt) 2015-10-13
CN102105473B (zh) 2013-05-08

Similar Documents

Publication Publication Date Title
CO6321284A2 (es) Compuestos triciclicos que contienen nitrogeno y su uso como antibacteriales
ATE432259T1 (de) Pyridinderivate als dipeptedyl-peptidase-hemmer
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
UY30499A1 (es) Derivados de amina utiles como agentes anticancerigenos
ECSP088258A (es) Inhibidores de serina proteasas
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
MX2011011094A (es) Derivados de prolina como inhibidores de catepsina.
MY140841A (en) Indozolone derivatives as 11b-hsd1 inhibitors
SMT201300096B (it) Inibitori di prolil idrossilasi
MX2009009540A (es) Inhibidores de metaloproteasa que contienen una porcion heterociclica.
DK2203430T3 (da) N-phenyl-dioxo-hydropyrimidiner anvendelige som inhibitorer for hepatitis C virus (HCV)
MX2010009736A (es) Compuesto heterociclico.
PE20140863A1 (es) Compuestos de benceno sustituidos con arilo o heteroarilo
CO6150146A2 (es) Derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas su preparacion y su aplicacion en terapeutica
AR051795A1 (es) Derivados de hidantoina inhibidores de metaloproteinasas
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
UA106763C2 (uk) Фуразанобензимідазоли як проліки для лікування пухлинних або аутоімунних захворювань
NO20082346L (no) Hydrazonderivater og anvendelser derav
SG146658A1 (en) Haloalkyl containing compounds as cysteine protease inhibitors
EA201071019A1 (ru) Кристаллические формы производных фениламинопиримидина
MX2009008925A (es) Compuestos de la formula (i) como inhibidores de proteasa de serina.
MX2007003913A (es) Alquil-piridinas como inhibidores de 11 beta para diabetes.
AR061134A1 (es) Derivados de tioxantina

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed